ATE215378T1 - Micrococcin antibiotika zur prävention und therapie der mastitis - Google Patents

Micrococcin antibiotika zur prävention und therapie der mastitis

Info

Publication number
ATE215378T1
ATE215378T1 AT97929226T AT97929226T ATE215378T1 AT E215378 T1 ATE215378 T1 AT E215378T1 AT 97929226 T AT97929226 T AT 97929226T AT 97929226 T AT97929226 T AT 97929226T AT E215378 T1 ATE215378 T1 AT E215378T1
Authority
AT
Austria
Prior art keywords
micrococcin
antibiotics
mastitis
infection
therapy
Prior art date
Application number
AT97929226T
Other languages
German (de)
English (en)
Inventor
Bruno Suri
Catherine Georges
John Edmondson Peel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE215378T1 publication Critical patent/ATE215378T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/05—Treating milk before coagulation; Separating whey from curd
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT97929226T 1996-06-20 1997-06-19 Micrococcin antibiotika zur prävention und therapie der mastitis ATE215378T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20
PCT/EP1997/003212 WO1997048408A2 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Publications (1)

Publication Number Publication Date
ATE215378T1 true ATE215378T1 (de) 2002-04-15

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97929226T ATE215378T1 (de) 1996-06-20 1997-06-19 Micrococcin antibiotika zur prävention und therapie der mastitis

Country Status (14)

Country Link
US (1) US6187800B1 (https=)
EP (1) EP0934075B1 (https=)
JP (1) JP2000513348A (https=)
CN (1) CN1119170C (https=)
AT (1) ATE215378T1 (https=)
AU (1) AU720243B2 (https=)
BR (1) BR9709812A (https=)
CA (1) CA2251779A1 (https=)
DE (1) DE69711661T2 (https=)
DK (1) DK0934075T3 (https=)
ES (1) ES2175425T3 (https=)
IL (1) IL126489A0 (https=)
PT (1) PT934075E (https=)
WO (1) WO1997048408A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
WO2002072617A1 (en) * 2001-03-13 2002-09-19 Yamanouchi Pharmaceutical Co., Ltd. Thiopeptide compounds
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
WO2004002451A1 (fr) * 2002-06-28 2004-01-08 Fang Chen Suppositoire a liberation controlee utilise dans un canal secreteur de lait
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
CN103006698A (zh) * 2006-10-10 2013-04-03 威斯康星旧生研究基金会 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法
KR20120005497A (ko) 2009-04-08 2012-01-16 위스콘신 얼럼나이 리서어치 화운데이션 유방내 유두 밀봉 제제 및 이를 사용하여 숙성된 치즈에서 시각적 결함을 감소 또는 제거시키는 방법
MX389960B (es) * 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2014121342A1 (en) * 2013-02-08 2014-08-14 Luoda Pharma Pty Limited Methods of treating topical microbial infections
US11491105B2 (en) * 2013-02-08 2022-11-08 Luoda Pharma Limited Methods of treating microbial infections, including mastitis
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
EP3848015A1 (en) * 2016-12-27 2021-07-14 Colgate-Palmolive Company Antiperspirant / deodorant composition
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use
WO2022245150A1 (ko) * 2021-05-21 2022-11-24 주식회사 에이엔제이사이언스 마크로코신 화합물을 포함하는 약학적 조성물 및 마크로코신 화합물의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2157985T3 (es) * 1993-08-20 2001-09-01 Novartis Ag Metodo para la prevencion y el tratamiento de la mastitis bovina.

Also Published As

Publication number Publication date
DE69711661D1 (de) 2002-05-08
EP0934075A2 (en) 1999-08-11
BR9709812A (pt) 1999-08-10
AU3341097A (en) 1998-01-07
CN1222081A (zh) 1999-07-07
AU720243B2 (en) 2000-05-25
DE69711661T2 (de) 2002-10-17
WO1997048408A3 (en) 1998-02-19
DK0934075T3 (da) 2002-06-10
US6187800B1 (en) 2001-02-13
JP2000513348A (ja) 2000-10-10
IL126489A0 (en) 1999-08-17
ES2175425T3 (es) 2002-11-16
PT934075E (pt) 2002-08-30
CA2251779A1 (en) 1997-12-24
WO1997048408A2 (en) 1997-12-24
CN1119170C (zh) 2003-08-27
EP0934075B1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
ATE215378T1 (de) Micrococcin antibiotika zur prävention und therapie der mastitis
Owens et al. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
SE9901647D0 (sv) Anapparatus for teat treatment
CA2260007A1 (en) Method for treating gastrointestinal damage
CN104379151A (zh) 药物组合物和乳腺炎的治疗
Nagahata et al. Effects of intramammary infusion of Bifidobacterium breve on mastitis pathogens and somatic cell response in quarters from dairy cows with chronic subclinical mastitis
Oliver et al. Antibiotic residues and prevalence of mastitis pathogen isolation in heifers during early lactation following prepartum antibiotic therapy
DE3778852D1 (de) Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4.
EP0301785A3 (en) Carboxamide derivatives of glycopeptides
ATE201995T1 (de) Verfahren zur prävention und behandlung der rindermastitis
Janosi et al. The use of the dry cow therapy in the control of bovine mastitis
Schultze et al. Nonlactating-cow therapy with a formulation of penicillin and novobiocin: therapeutic and prophylactic effects
ATE279939T1 (de) Phytase zur vorbeugung oder behandlung von mastitis
US7045510B2 (en) Methods for prevention and treatment of mastitis
NZ503145A (en) 8a-Azalides as veterinary antimicrobial agents to treat bacterial respiratory infection
Owens et al. Therapeutic and prophylactic effect of prepartum antibiotic infusion in heifers
Buddle et al. Aspects of the epidemiology of bovine staphylococcal mastitis
CN201029956Y (zh) 动物乳腺炎治疗仪
Hogan et al. Efficacy of parenteral vitamin E for treating bovine mastitis.
DE3772255D1 (de) Behandlungsverfahren fuer milch zur erhaltung von kaese.
Žilaitis et al. Effect of low intensity laser radiation on cow’s milk microflora and somatic cell count
Yuliza Purba et al. Effect of temporary cessation of milking on the innate immune components in goat milk
WO2024192151A3 (en) Method of dosing vapendavir to treat enterovirus infections
CA3297227A1 (en) Autonomous system and methods thereof for treatment and injection of medicaments, beneficial agents and the like in livestock and wild animals

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee